Mar 012022
 
Drug Name
Active Ingredient(s)
Approval Date
FDA-Approved Use on Approval Date
Press Release
Drug Trials Snapshot
Vonjo pacritinib 2/28/2022 To treat intermediate or high-risk primary or secondary myelofibrosis in adults with low platelets
Pyrukynd mitapivat 2/17/2022 To treat hemolytic anemia in pyruvate kinase deficiency Drug Trials Snapshot
Enjaymo sutimlimab-jome 2/4/2022 To decrease the need for red blood cell transfusion due to hemolysis in cold agglutinin disease Drug Trials Snapshot

Sorry, the comment form is closed at this time.